In participants with type 2 diabetes receiving the 8mg weekly dose, baseline A1C averaged 8.1%
The CyLoc technology encloses each glutathione molecule in a dextrin fiber delivery cage to maintain its integrity until it reaches the desired point of delivery in the body
Healthcare providers also give glutathione intravenously to prevent anemia in kidney patients undergoing hemodialysis, prevent kidney problems after heart bypass surgery, treat Parkinson's disease, improve blood flow and decrease clotting in individuals with atherosclerosis, treat diabetes, and prevent the toxic side effects of chemotherapy
Plus, it features a 21.5-in, full HD touchscreen with 360-degree swivel, front-facing speakers, Bluetooth 5.2 connectivity, and a USB-C charging port for your devices